Table 1 Estimates for utility, mortality, and other parameters
Parameters | Value | Source |
|---|---|---|
Transition probabilities yearly | ||
Risk of progression from mild to moderate stage in observation | 0.149 | Tang et al. [23] |
Risk of progression from moderate to severe in treatment B | 0.056 | Tang et al. [23] |
Risk of progression in treatment A at 5 years | 0.200 | CNTGS [19] |
Risk of progression from mild to moderate stage in treatment A | 0.044 | tertiary hospital |
Risk of progression from moderate to severe stage in treatment A | 0.018 | tertiary hospital |
Utility score | ||
Mild NTG | 0.80 | Tang et al. [23] |
Moderate NTG | 0.75 | Tang et al. [23] |
Severe NTG | 0.71 | Tang et al. [42] |
Natural Mortality rates by age group, years | ||
65—69 | 0.364% | Tang et al. [23] |
70—74 | 0.518% | Tang et al. [23] |
Increased mortality risk for different groups, odds ratio | ||
People with mild, moderate, or severe POAG | 1.8 | Tang et al. [23] |